{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:01Z","timestamp":1787009941713,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Dual antiplatelet therapy is a standard treatment after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS), but the optimal monotherapy agent post-dual antiplatelet therapy remains unclear. Clopidogrel and aspirin are widely used, yet their comparative effectiveness and safety in this patient population have not been fully established. This systematic review and meta-analysis compared the efficacy and safety of clopidogrel and aspirin monotherapy following PCI in patients with ACS. A comprehensive search of PubMed, Embase, and Web of Science was conducted from inception to March 31, 2025. Randomized controlled trials (RCTs) comparing clopidogrel and aspirin monotherapy in adult ACS patients post-PCI were included. Primary outcomes were all-cause death, myocardial infarction (MI), and ischemic stroke. Secondary outcomes included target-vessel and target-lesion revascularization, cardiovascular and noncardiovascular death, and stent thrombosis. The risk of bias was assessed using the Cochrane RoB 2 tool, and the GRADE methodology was applied to evaluate the certainty of evidence. Three RCTs involving 16,056 patients (clopidogrel: 8103; aspirin: 7953) were included. Clopidogrel significantly reduced MI (risk ratio = 0.71; 95% confidence interval: 0.55\u20130.92;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.01) and target-vessel revascularization (risk ratio = 0.77; 95% confidence interval: 0.60\u20130.97;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.03). No significant differences were found in all-cause death, ischemic stroke, or other secondary outcomes. Sensitivity analysis suggested a potential reduction in noncardiovascular death favoring clopidogrel. Clopidogrel monotherapy after PCI may offer superior protection against MI and target-vessel revascularization compared with aspirin, with no increased risk of death or stroke.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000000971","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:01:13Z","timestamp":1750410073000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Clopidogrel Versus Aspirin Monotherapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1097","author":[{"given":"Muhammad Abdullah","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa Arshad Azam","family":"Raja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizaz","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaryab","family":"Bacha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan Ahmad","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umama","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan","family":"Shahid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad","family":"Saif","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Afridi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allahdad","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nishtar Medical University, Multan, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibran","family":"Ikram","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Department, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20250620"},{"key":"R2-20250620","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association.","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"R3-20250620","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/cvr\/cvac105","article-title":"Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.","volume":"119","author":"Nicolas","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R4-20250620"},{"key":"R5-20250620","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction.","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250620","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines.","volume":"82","author":"Virani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R8-20250620","doi-asserted-by":"crossref","first-page":"e002816","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents.","volume":"9","author":"Park","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R9-20250620","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.","volume":"348","author":"Dennis","year":"1996","journal-title":"Lancet"},{"key":"R10-20250620","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(25)00449-0","article-title":"Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.","volume":"405","author":"Choi","year":"2025","journal-title":"Lancet"},{"key":"R11-20250620","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1093\/eurheartj\/ehae617","article-title":"Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.","volume":"45","author":"Watanabe","year":"2024","journal-title":"Eur Heart J"},{"key":"R12-20250620","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study.","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"key":"R13-20250620","doi-asserted-by":"crossref","first-page":"e24326","DOI":"10.1002\/clc.24326","article-title":"Clopidogrel versus aspirin as monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome receiving a drug\u2010eluting stent: a systematic literature review and meta\u2010analysis.","volume":"47","author":"Sibbing","year":"2024","journal-title":"Clin Cardiol"},{"key":"R14-20250620","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R15-20250620","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R16-20250620","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jclinepi.2015.12.006","article-title":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments.","volume":"74","author":"Santesso","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R17-20250620","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/ds.DS-D-22-00154","article-title":"Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial.","volume":"41","author":"Shao","year":"2023","journal-title":"Dermatol Sin"},{"key":"R18-20250620","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R19-20250620","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R20-20250620","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.cpcardiol.2022.101174","article-title":"Clopidogrel vs aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis.","volume":"48","author":"Bryan","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R21-20250620","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1055\/a-1853-2952","article-title":"Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.","volume":"122","author":"Tasoudis","year":"2022","journal-title":"Thromb Haemost"},{"key":"R22-20250620","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"key":"R23-20250620","doi-asserted-by":"crossref","first-page":"1265983","DOI":"10.3389\/fcvm.2023.1265983","article-title":"Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis.","volume":"10","author":"Liu","year":"2023","journal-title":"Front Cardiovasc Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:01:16Z","timestamp":1750410076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000971","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}